Tumor-Extrinsic Axl Expression Shapes an Inflammatory Microenvironment Independent of Tumor Cell Promoting Axl Signaling in Hepatocellular Carcinoma.
Kristina BreiteneckerDenise HeidenTobias DemmerGerhard WeberAna-Maria PrimoracViola HedrichGregor OrtmayrThomas GruenbergerPatrick StarlingerDietmar Herndler-BrandstetterIros BarozziWolfgang MikulitsPublished in: International journal of molecular sciences (2024)
The activation of the receptor tyrosine kinase Axl by Gas6 is a major driver of tumorigenesis. Despite recent insights, tumor cell-intrinsic and -extrinsic Axl functions are poorly understood in hepatocellular carcinoma (HCC). Thus, we analyzed the cell-specific aspects of Axl in liver cancer cells and in the tumor microenvironment. We show that tumor-intrinsic Axl expression decreased the survival of mice and elevated the number of pulmonary metastases in a model of resection-based tumor recurrence. Axl expression increased the invasion of hepatospheres by the activation of Akt signaling and a partial epithelial-to-mesenchymal transition (EMT). However, the liver tumor burden of Axl +/+ mice induced by diethylnitrosamine plus carbon tetrachloride was reduced compared to systemic Axl -/- mice. Tumors of Axl +/+ mice were highly infiltrated with cytotoxic cells, suggesting a key immune-modulatory role of Axl. Interestingly, hepatocyte-specific Axl deficiency did not alter T cell infiltration, indicating that these changes are independent of tumor cell-intrinsic Axl. In this context, we observed an upregulation of multiple chemokines in Axl +/+ compared to Axl -/- tumors, correlating with HCC patient data. In line with this, Axl is associated with a cytotoxic immune signature in HCC patients. Together these data show that tumor-intrinsic Axl expression fosters progression, while tumor-extrinsic Axl expression shapes an inflammatory microenvironment.
Keyphrases
- tyrosine kinase
- epidermal growth factor receptor
- poor prognosis
- stem cells
- single cell
- oxidative stress
- type diabetes
- cell proliferation
- signaling pathway
- cell therapy
- case report
- ejection fraction
- metabolic syndrome
- long non coding rna
- mesenchymal stem cells
- machine learning
- prognostic factors
- skeletal muscle
- smoking cessation
- replacement therapy